SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-23-005553
Filing Date
2023-12-01
Accepted
2023-12-01 16:19:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3462
  Complete submission text file 0001950047-23-005553.txt   4910
Mailing Address C/O DYAX CORP. 300 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address
MIGAUSKY GEORGE V (Reporting) CIK: 0001134365 (see all company filings)

Type: 144

Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Subject) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 144 | Act: 33 | File No.: 001-38906 | Film No.: 231459790
SIC: 2836 Biological Products, (No Diagnostic Substances)